AWMDMG
TPST icon

Austin W. Marxe & David M. Greenhouse’s Tempest Therapeutics TPST Stock Holding History

Austin W. Marxe & David M. Greenhouse’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1.32M Hold
27
– – 0.18% 110
2014
Q2 		$731K Sell
27
-51
-65% -$1.2M 0.09% 121
2014
Q1 		$2.04M Buy
78
+62
+388% +$1.76M 0.23% 91
2013
Q4 		$428K Buy
16
+6
+60% +$165K 0.05% 121
2013
Q3 		$297K Buy
+10
New +$355K 0.04% 120

Other funds holding TPST

DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
BCM
BBT Capital Management Fort Worth, Texas $85.5M AUM 11.09% 1-Year Est. Return
TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Austin W. Marxe & David M. Greenhouse's TPST Position: Q3 2014 in Review

Austin W. Marxe & David M. Greenhouse held its Tempest Therapeutics (TPST) position steady in Q3 2014 at 27 shares worth $1.32M. The position accounts for 0.18% of the portfolio, ranked #110.

Austin W. Marxe & David M. Greenhouse first reported a position in TPST in Q3 2013 and has held it in 5 quarters since. The position peaked at $2.04M in Q1 2014. 53 funds tracked by Wall St. Rank hold TPST as of Q3 2014.

  • Austin W. Marxe & David M. Greenhouse held 27 shares of Tempest Therapeutics worth $1.32M as of Q3 2014.
  • Austin W. Marxe & David M. Greenhouse left its Tempest Therapeutics share count unchanged in Q3 2014.
  • Tempest Therapeutics made up 0.18% of Austin W. Marxe & David M. Greenhouse's portfolio in Q3 2014, its #110 holding.
  • Austin W. Marxe & David M. Greenhouse first reported a position in Tempest Therapeutics in Q3 2013 and has held it in 5 quarters since.
  • Austin W. Marxe & David M. Greenhouse's Tempest Therapeutics position peaked at $2.04M in Q1 2014.
  • 53 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q3 2014.

Based on Austin W. Marxe & David M. Greenhouse's 13F filing for Q3 2014, filed 14 Nov 2014.